Road warrior: Hal Barron's global R&D crusade at GSK comes with a hefty $800,000-plus travel budget
We already knew that GSK R&D chief Hal Barron got paid considerably more than his boss, Emma Walmsley — who’s at the bottom of the list of major league biopharma CEOs when it comes to compensation. It turns out he also gets a much bigger travel budget.
Basic subscription required
Unlock this story instantly and join 57,900+ biopharma pros reading Endpoints daily — and it's free.